tm
Seeing Is Believing
tm
Seeing Is Believing
FDMT is currently covered by 7 analysts with an average price target of $29.08. This is a potential upside of $16.94 (139.54%) from yesterday's end of day stock price of $12.14.
4D Molecular Therapeutics's activity chart (see below) currently has 67 price targets and 84 ratings on display. The stock rating distribution of FDMT is 92.86% BUY and 7.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 35.6% with an average time for these price targets to be met of 108.95 days.
Highest price target for FDMT is $36, Lowest price target is $17, average price target is $29.08.
Most recent stock forecast was given by TAZEEN AHMAD from BAML on 29-Sep-2026. First documented stock forecast 04-Jan-2021.
Currently out of the existing stock ratings of FDMT, 13 are a BUY (92.86%), 1 are a HOLD (7.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Jan-2021
$33
$20.86 (171.83%)
$31
19 days ago
(29-Sep-2026)
1/4 (25%)
$18.51 (127.74%)
14
Hold Since 14-Sep-2026
$20
$7.86 (64.74%)
1 months 4 days ago
(14-Sep-2026)
1/5 (20%)
$6.24 (45.35%)
104
Buy Since 28-Apr-2023
$36
$23.86 (196.54%)
$36
2 months 28 days ago
(20-Jul-2026)
0/12 (0%)
$24.91 (224.62%)
Buy Since 05-Jul-2023
$26
$14.4 (124.14%)
$26
6 months 29 days ago
(19-Mar-2026)
3/10 (30%)
$17.02 (189.53%)
201
Buy Since 05-Feb-2024
$35
$23.4 (201.72%)
$32
6 months 29 days ago
(19-Mar-2026)
1/8 (12.5%)
$26.02 (289.76%)
51
What is FDMT (4D Molecular Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on FDMT (4D Molecular Therapeutics)?
Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics)?
Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics)?
Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics)?
